Experience

Observia
• France
• Wellness and Fitness Services
• 1 - 100 Employee
• Consulting Director

  • Jul 2019 - Present


Alcimed

• France
• Business Consulting and Services
• 200 - 300 Employee

• Senior Strategy Consultant - Healthcare and private equity

  • 2015 - Jul 2019

   Led and executed more than 20 strategic consultancy projects for healthcare players: o Industries: pharmaceuticals (oncology, rare diseases, vaccines, etc.), medical devices (orthopedics, diagnostics, etc.) healthcare IT, biotech, etc. o Geographies: Middle East, Europe, CIS, USA. o Examples of the most recent projects: - Investigated the public vaccination policies for a major vaccine producer in Central Asian countries … Show more  Led and executed more than 20 strategic consultancy projects for healthcare players: o Industries: pharmaceuticals (oncology, rare diseases, vaccines, etc.), medical devices (orthopedics, diagnostics, etc.) healthcare IT, biotech, etc. o Geographies: Middle East, Europe, CIS, USA. o Examples of the most recent projects: - Investigated the public vaccination policies for a major vaccine producer in Central Asian countries (Kazakhstan, Uzbekistan, etc.) and helped defining the business strategy of market penetration and of communication with local authorities; - Accompanied a Tier 1 pharmaceutical players in their market assessment of Middle Eastern countries (Saudi Arabia, Iran, Egypt, etc.) for oncology and helped defining market access routes; - Developed distribution business models in Russia and Africa for major medical device producers. o Modeled prevalence and incidence of patients suffering from oncological and rare diseases in specific countries thus helping my clients in establishing sales forecasts and business plans.  Performed over 20 strategic due diligences projects for private equity funds willing to invest in biotech and other life science industry players: o Targeted companies for acquisition assessment included: producers of pharma-grade hyaluronic acid, herbal extract, amino acids, viral vectors, etc.  Strongly contributed to the commercial development of Alcimed by the expertise in project structuring, methodology to be employed means to be attributed to the project execution, etc.  Animated a workshops and regularly performed interviews with KOLs and health authorities in number of European, Middle East, US and CIS countries.  Managed ad-hoc teams of consultants. Show less  Led and executed more than 20 strategic consultancy projects for healthcare players: o Industries: pharmaceuticals (oncology, rare diseases, vaccines, etc.), medical devices (orthopedics, diagnostics, etc.) healthcare IT, biotech, etc. o Geographies: Middle East, Europe, CIS, USA. o Examples of the most recent projects: - Investigated the public vaccination policies for a major vaccine producer in Central Asian countries … Show more  Led and executed more than 20 strategic consultancy projects for healthcare players: o Industries: pharmaceuticals (oncology, rare diseases, vaccines, etc.), medical devices (orthopedics, diagnostics, etc.) healthcare IT, biotech, etc. o Geographies: Middle East, Europe, CIS, USA. o Examples of the most recent projects: - Investigated the public vaccination policies for a major vaccine producer in Central Asian countries (Kazakhstan, Uzbekistan, etc.) and helped defining the business strategy of market penetration and of communication with local authorities; - Accompanied a Tier 1 pharmaceutical players in their market assessment of Middle Eastern countries (Saudi Arabia, Iran, Egypt, etc.) for oncology and helped defining market access routes; - Developed distribution business models in Russia and Africa for major medical device producers. o Modeled prevalence and incidence of patients suffering from oncological and rare diseases in specific countries thus helping my clients in establishing sales forecasts and business plans.  Performed over 20 strategic due diligences projects for private equity funds willing to invest in biotech and other life science industry players: o Targeted companies for acquisition assessment included: producers of pharma-grade hyaluronic acid, herbal extract, amino acids, viral vectors, etc.  Strongly contributed to the commercial development of Alcimed by the expertise in project structuring, methodology to be employed means to be attributed to the project execution, etc.  Animated a workshops and regularly performed interviews with KOLs and health authorities in number of European, Middle East, US and CIS countries.  Managed ad-hoc teams of consultants. Show less


A.T. Kearney
• Brazil
• Accounting
• Business Consultant

  • Mar 2013 - Dec 2015


Air Liquide

• France
• Chemical Manufacturing
• 700 & Above Employee

• Business Consultant

  • Mar 2012 - Nov 2013

  - Analysis of Ukrainian industrial gas market - Identifiction of potential acquisition targets - Valuation of Ukrainian companies evolving in industrial gas trading - Analysis of Ukrainian industrial gas market - Identifiction of potential acquisition targets - Valuation of Ukrainian companies evolving in industrial gas trading


Sumitomo Mitsui Banking Corporation
• United States
• Financial Services
• 700 & Above Employee
• Financial Analyst

  • 2011 - 2012

Gazprom Marketing & Trading
• United Kingdom
• Oil and Gas
• 200 - 300 Employee
• Business Analyst

  • May 2009 - Sep 2010